IFNA1 and animal viral hepatitis: Since IFNs possess antiviral activity, antiproliferative activity and various immunoregulatory activities, IFN therapy is used to treat patients with chronic viral hepatitis or certain types of cancer including malignant melanoma, acquired immunodeficiency syndrome-related Kaposi’s sarcoma and some hematopoietic malignancies [1,2].